Bright Minds Biosciences, Inc. (DRUG)
49.94
-2.06
(-3.96%)
USD |
NASDAQ |
Oct 08, 10:29
Bright Minds Biosciences Market Cap : 492.61M for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 512.93M |
| October 06, 2026 | 475.94M |
| October 05, 2026 | 491.13M |
| October 02, 2026 | 500.01M |
| October 01, 2026 | 485.41M |
| September 30, 2026 | 491.43M |
| September 29, 2026 | 490.64M |
| September 28, 2026 | 509.58M |
| September 25, 2026 | 510.96M |
| September 24, 2026 | 527.83M |
| September 23, 2026 | 571.33M |
| September 22, 2026 | 598.45M |
| September 21, 2026 | 586.52M |
| September 18, 2026 | 601.51M |
| September 17, 2026 | 607.14M |
| September 16, 2026 | 583.07M |
| September 15, 2026 | 594.02M |
| September 14, 2026 | 625.19M |
| September 11, 2026 | 623.21M |
| September 10, 2026 | 641.17M |
| September 09, 2026 | 641.76M |
| September 08, 2026 | 660.01M |
| September 04, 2026 | 642.74M |
| September 03, 2026 | 670.96M |
| September 02, 2026 | 701.53M |
| Date | Value |
|---|---|
| September 01, 2026 | 698.77M |
| August 31, 2026 | 707.55M |
| August 28, 2026 | 718.21M |
| August 27, 2026 | 735.22M |
| August 26, 2026 | 755.89M |
| August 25, 2026 | 784.10M |
| August 24, 2026 | 759.78M |
| August 21, 2026 | 763.68M |
| August 20, 2026 | 774.92M |
| August 19, 2026 | 835.88M |
| August 18, 2026 | 828.98M |
| August 17, 2026 | 784.00M |
| August 14, 2026 | 754.01M |
| August 13, 2026 | 769.40M |
| August 12, 2026 | 782.91M |
| August 11, 2026 | 787.42M |
| August 10, 2026 | 792.72M |
| August 07, 2026 | 778.39M |
| August 06, 2026 | 792.82M |
| August 05, 2026 | 784.97M |
| August 04, 2026 | 758.97M |
| August 03, 2026 | 723.94M |
| July 31, 2026 | 718.83M |
| July 30, 2026 | 732.28M |
| July 29, 2026 | 697.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 216.56B |
| Lineage Cell Therapeutics, Inc. | 237.45M |
| Recursion Pharmaceuticals, Inc. | 2.104B |
| Agenus, Inc. | 310.24M |
| BioCryst Pharmaceuticals, Inc. | 2.098B |
Market Cap Related Metrics
| PEG Ratio | -0.1994 |
| Price to Book Value | 2.271 |
| Price | 49.94 |
| Earnings Yield | -4.17% |
| PEGY Ratio | -0.1994 |